30 participants
An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-25
- Start Date:
- 2024-10-15
- Completion:
- 2025-10-30
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet